• Client Portal:
  • CES
inquiry@psomagen.com(301) 251-1007
Psomagen
  • Facebook
  • Linkedin
  • Twitter
  • Instagram
  • Personal DNA Tests
    • Gene & GutBiome Combo
    • Gutbiome+
    • Shop Now
  • Research Sequencing
    • Next Generation Sequencing
      • Whole Genome
      • Exome and Targeted
      • Transcriptome/RNA
      • Metagenome
      • Epigenome Sequencing Services
      • Low Pass Sequencing
      • Bioinformatics
    • Sanger Sequencing
      • Standard Sequencing
      • Custom Sequencing
      • EZ-Seq/EZ-Care
    • Microarray Services
  • Clinical Sequencing
    • Clinical Whole Genome
    • Clinical Whole Exome
  • COVID-19 Test
    • SalivaDirect
  • Support
    • NGS Order Guide
    • CES Order Guide
    • Clinical Order Guide
  • About
    • About
    • Investor Information
      • Financial Information
      • Company Announcements
      • Investment Inquiries
    • CLIA/CAP Certification
    • Current Promotions
    • Blog
      • Sequencing
      • Health & Genomics
    • Scholarship
    • Careers
  • Contact Us
  • Menu

Pages

  • COVID Test
  • SalivaDirect
  • Gene & GutBiome Combo
  • GutBiome+
  • Home 2020
  • Genetic Testing
  • Clinical
    • Clinical Whole Genome
    • Clinical Exome
    • Variant Validation
  • Next Generation Sequencing
    • Whole Genome
    • Transcriptome/RNA
    • Exome and Targeted
    • Epigenome Sequencing Services
    • Metagenome
    • Low Pass Sequencing
    • Bioinformatics
  • Sanger Sequencing
    • Standard Sequencing
    • Custom Sequencing
    • EZ-Seq/EZ-Care
  • Microarray Services
  • Clinical Order Guide
  • NGS Order Guide
  • CES Order Guide
  • About
  • Blog
  • Health & Genomics
  • Sequencing
  • CLIA/CAP Certification
  • Current Promotions
  • Careers
  • Scholarship
  • Company Announcements
  • Contact Us
  • Financial Information
  • Investment Inquiries

Psomagen, Inc.

Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.

Contact Details

inquiry@nullpsomagen.com
(301) 251-1007

ROCKVILLE, MARYLAND (HQ)
CLIA: 21D2062464  |  CAP: 8742212

BROOKLYN, NEW YORK

CAMBRIDGE, MASSACHUSETTS

STERLING, VIRGINIA
CLIA: 49D2172599

KOSDAQ: PSOMAGEN INC (950200)

Psomagen Logo White
© Copyright - Psomagen, Inc. | All sequencing done in the United States | Site Map
  • Facebook
  • Linkedin
  • Twitter
  • Instagram
Scroll to top